Personalized treatment for early water breaking could extend pregnancy safely

NCT ID NCT07107477

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial investigates whether using a lab test (IL-6) from amniotic fluid to guide antibiotic and steroid treatment can safely prolong pregnancy in people whose water breaks too early (preterm premature rupture of membranes, or pPROM). Participants are randomly assigned to either standard care or a tailored approach where weekly amniocentesis measures IL-6 levels to decide when to give steroids and antibiotics. The study aims to see if this personalized strategy helps the pregnancy last more than 7 days after pPROM and improves outcomes for both parent and baby.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

amniocentesis-guided tailored antibiotic and steroid therapy

What this could lead to

If successful, this approach could help doctors time treatments better, reduce unnecessary medication, and safely extend pregnancy after early water breaking.

What could go wrong

This is a Phase 3 trial with 138 participants, so results may not apply to all. Amniocentesis carries small risks like infection or cramping, and the tailored strategy may not improve outcomes over standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preterm premature rupture of the membranes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • General University Hospital in Prague

    RECRUITING

    Prague, 128 08, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institute for Mother and Child Care in Prague - Podolí

    RECRUITING

    Prague, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Brno

    RECRUITING

    Brno, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••